Subscriber login:
Remember me
CLINICAL & FORMULARY MANAGEMENT STRATEGY
Review Formulary Management Considerations for Opportunities and Strategies and P&T Committee Planning Support
Access Published Guidelines, Health Outcomes, Pharmacoeconomics, and Clinical Trials
Anticipate Market Shifts, Pipeline Events, Manufacturer
Life-Cycle Management Strategies, and
Financial Implications
Understand Key Clinical, Cost, Utilization, Reimbursement, and Market-Competition Factors
IPD's Payer & Provider Insights combine advanced pharmaceutical landscape market visibility with a team of Executive Clinical Pharmacists to provide comprehensive pharmacy and therapeutic management strategy, supporting formulary, clinical, contracting, and market-access decisions.
Our subscribers gain around-the-clock access to IPD's proprietary web platform, real-time alerts, comprehensive reports, new drug reviews, podcast episodes, and expert consultations.
-
In-depth analysis regarding drug availability, clinical data, clinical pipeline tracking, evidence-based clinical pathways, preferred products, and site of care
-
Disease class-specific strategy reports, drug alerts, pipeline trend reports, and new-drug reviews
-
Assessments of potential new brand product prevalence and pricing impacts prior to launch
-
Extensive trend analysis examining brand vs. generic clinical pathways, cost-effective therapies, and payer perspectives
-
Pricing specific to competitive landscape including generic-launch projections, FDA action dates, sales, therapy costs, and price changes
-
Trend reports highlighting disease classes and drug events important to payers, systems, and manufacturers throughout the country
-
Clinical criteria, formulary coverage, step therapy, and limited distribution network tracking